KalVista Pharmaceuticals, Inc. (KALV)

16.23 +0.02 (+0.12%) USD  |  NASDAQ  |  Mar 06, 16:00
16.31 +0.08 (+0.49%) After-Hours: 20:00
More

KalVista Pharmaceuticals Net Income (Annual)

Net Income (Annual) Chart

View Net Income (Annual) for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
Modular Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade